Back to results
US 2022/0008489 A1Published application
Agent for improving mitochondrial function
AssigneesMeiji Co., Ltd., National University Corporation Hamamatsu University School of Medicine
InventorsTakashi ITO, Mitsutoshi SETOU, Satoru OZAKI, Chinami MIZOGUCHI, Yukio ASAMI
Life of this patent
Estimating the term…
Abstract
The present invention provides a mitochondrial function-improving agent containing a lactic acid bacterium belonging to Lactobacillus farciminis or Pediococcus acidilactici, a culture of the lactic acid bacterium, or a culture supernatant of the lactic acid bacterium.
Claims10
1-4. (canceled)
A method for improving mitochondrial function, comprising:
- administering a therapeutically effective amount of a lactic acid bacterium belonging to Lactobacillus farciminis or Pediococcus acidilactici, a culture of the lactic acid bacterium, or a culture supernatant of the lactic acid bacterium to a subject in need thereof.
A composition, comprising:
- a lactic acid bacterium, a culture of the lactic acid bacterium, or a culture supernatant of the lactic acid bacterium,
- wherein the lactic acid bacterium is Lactobacillus farciminis OLL204082 strain (accession number:
- NITE BP-02635) or Pediococcus acidilactici OB7260 strain (accession number:
- NITE BP-02634).
1 more element
Dependencies are inferred from the claim text.